Application of supramolecular fluorescence sensing array in aspect of intracellular bacteria identification
By constructing a supramolecular fluorescent sensing array and utilizing a sensing unit loaded with azocalixarane fluorescent indicators, the problem of intracellular bacterial type identification was solved, enabling rapid and accurate bacterial differentiation and antibiotic selection, thereby improving the precision and safety of treatment.
Patent Information
- Application Number
- CN202411045198.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-26
AI Technical Summary
Current technologies struggle to quickly and accurately identify intracellular bacterial types, leading to poor antibiotic treatment efficacy and potentially causing inappropriate and/or overuse, which in turn exacerbates antibiotic resistance in bacteria.
A supramolecular fluorescence sensing array was constructed, and sensing units loaded with fluorescent indicators using azocalixarene were used to identify intracellular bacteria through fluorescence response. The characteristic fingerprint spectrum was formed based on the thermodynamic differences in interaction and the kinetic differences in hypoxia reduction.
It enables convenient, rapid, and accurate differentiation of intracellular bacteria, provides valuable guidance for antibiotic selection, avoids the misuse and overuse of antibiotics, and improves the precision of treatment.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of supramolecular sensing technology and disease diagnosis, and relates to a supramolecular fluorescence sensing array that accurately identifies intracellular bacteria in a simple and rapid manner, provides guidance for the correct selection of antibiotics, and can be used for the treatment of anti-intracellular bacterial infections under the guidance of accurate diagnosis. Background Art
[0002] Intracellular bacterial infections pose an extremely severe challenge to humans and are associated with a variety of serious diseases, including sepsis, osteomyelitis, and cancer metastasis. Cunning bacteria hide in macrophages, not only cannot be cleared by the immune system, but can also spread from the initial infection site and invade various non-phagocytic cell types in the tissue. There are two main reasons why clinical treatment for intracellular bacteria is not effective: (1) the inability to quickly and accurately identify the specific type of bacteria hinders timely and accurate symptomatic treatment; (2) host cells act as a protective barrier for bacteria due to their cell membrane barriers, resulting in poor accumulation of antibiotics in cells. These facts may lead to inappropriate and / or excessive use of antibiotics, thereby exacerbating bacterial antibiotic resistance. Among them, accurate identification of the type of intracellular pathogenic bacteria is a key prerequisite for achieving precision treatment, but it still faces huge challenges. (See: 1) Fu, A.; Yao, B.; Dong, T.; Chen, Y.; Yao, J.; Liu, Y.; Li, H.; Bai, H.; Liu, X.; Zhang, Y.; Wang, C.; Guo, Y.; Li, N.; Cai, S., Tumor-resident intracellular microbiota promotes metastatic colonization inbreast cancer. Cell 2022, 185, 1356-1372. 2) Fu, F.; Zhang, Y.; Li, L.; Wang, H.; Li, Q.; Tao, X.; Song, Y.; Song, E., Intracellular pathogen detection based on dual-recognition units constructed fluorescence energytransfer resonance nanoprobe. Anal. Chem. 2020, 92, 11462-11468.) The sensor array generates a unique fingerprint for each analyte through the interactive response between multiple sensing units and multiple analytes. This property makes it very suitable for complex systems, such as the discrimination of intracellular bacteria. Supramolecular chemistry provides a powerful way to build sensor arrays. Its inherent dynamic and reversible properties make it easy to build sensor units that can produce information-rich patterns, thereby enhancing the ability to distinguish. After the bacterial species is determined, the symptomatic treatment can be given. Summary of the invention
[0003] The present invention mainly constructs a supramolecular fluorescent sensor array for distinguishing intracellular bacteria, thereby providing valuable guidance for formulating appropriate treatment plans. Considering the hypoxic microenvironment caused by bacterial infection, a series of hypoxia-responsive azocalixarene derivatives encapsulate fluorescent indicators to form the units of the supramolecular sensor array. The supramolecular fluorescent sensor array shows application potential in the diagnosis of intracellular bacterial infection.
[0004] To achieve the above object, the present invention discloses the following technical solution: A supramolecular fluorescent sensor array, characterized in that it is composed of eight sensor units formed by loading azocalixarene with a fluorescent indicator to form a sensor array, wherein the molar concentration ratio of azocalixarene to the fluorescent indicator is 1:1; the fluorescent indicator is 1,1',3,3,3',3'-hexamethylindole dicarbonyl cyanine; The structure of the azocalixarene is as follows:
[0005] The present invention further discloses a method for preparing a supramolecular fluorescence sensor array, which is characterized by being carried out in the following steps: (1) mixing aqueous solutions of lactose azocalix[4]arene, galactose azocalix[4]arene, mannose azocalix[4]arene, glucose azocalix[4]arene, lysine azocalix[4]arene, serine azocalix[4]arene, carboxy azocalix[4]arene and sulfonated azocalix[4]arene with an aqueous solution of probe 1,1',3,3,3',3'-hexamethylindolyl dicarbonyl cyanine at a molar concentration ratio of 1:1; (2) Each azocalixarene cavity-bound fluorescent probe molecule forms a supramolecular complex. The final concentration of the eight supramolecular complexes is 200 μmol / L for subsequent dilution. (3) These eight supramolecular complexes are used as sensing units to construct a sensing array, which is then co-incubated with analytes to test the fluorescence response intensity generated by the sensing array; The preparation method of the lysine azocalix[4]arene is as follows: 0.20 mmol of carboxy azocalix[4]arene, 2.0 mmol of 1-ethyl-(3-dimethylaminopropyl)carbodiimide and 2.0 mmol of N-hydroxysuccinimide are dissolved in 20 ml of N,N-dimethylformamide, the solution is stirred at room temperature for 2 hours, and precipitated with excess water; the precipitate is dissolved in 40 ml of N,N-dimethylformamide, added to a round-bottom flask pre-mixed with 1.6 mmol of N(e)-Boc-l-lysine, 2.0 mmol of sodium carbonate, 10 ml of N,N-dimethylformamide and 10 ml of water, the mixture is stirred at room temperature for 24 hours, and precipitated with 300 ml of dilute hydrochloric acid; the precipitate is placed in 50 ml of trifluoroacetic acid and stirred for 24 hours, the liquid is evaporated to dryness, and the obtained solid is recrystallized with methanol and water to obtain 272 mg of brick red lysine azocalix[4]arene; The preparation method of the serine azocalix[4]arene is as follows: 0.20 mmol of carboxy azocalix[4]arene, 2.0 mmol of 1-ethyl-(3-dimethylaminopropyl)carbodiimide and 2.0 mmol of N-hydroxysuccinimide are dissolved in 20 ml of N,N-dimethylformamide, stirred at room temperature for 2 hours, and precipitated with excess water; the precipitate is dissolved in 40 ml of N,N-dimethylformamide, added to a round-bottom flask pre-mixed with 1.6 mmol of l-serine, 2.0 mmol of sodium carbonate, 10 ml of N,N-dimethylformamide and 10 ml of water, stirred the mixture at room temperature for 24 hours, and precipitated with 300 ml of dilute hydrochloric acid. The precipitate is recrystallized with methanol and water to obtain 235 mg of brick-red serine azocalix[4]arene.
[0006] The present invention further discloses the application of supramolecular fluorescence sensor array in the diagnosis of intracellular bacterial infection types. As a proof of concept, Salmonella typhimurium, Listeria monocytogenes, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Klebsiella pneumoniae, and Streptococcus mutans were selected as target analytes. These bacteria were first co-incubated with macrophages to construct an intracellular pathogen infection model. Subsequently, the eight-element supramolecular sensor array was co-incubated with eight types of intracellular bacteria, and five parallel experiments were performed. The fluorescence response signal generated by the supramolecular sensor array for each intracellular bacterium was processed by linear discriminant analysis. The experimental results show that all tested intracellular bacterial analytes are distinguished on the two-dimensional scoring map of linear discriminant analysis, which indicates that the supramolecular sensor array can be used to distinguish and discriminate intracellular bacteria. In addition, in mouse infected cell samples, the supramolecular sensor array also demonstrated the ability to discriminate intracellular bacterial infections.
[0007] The present invention is described in more detail as follows: (1) A method for constructing a supramolecular fluorescence sensing array for distinguishing intracellular bacteria Lactose azocalix[4]arene, galactose azocalix[4]arene, mannose azocalix[4]arene, glucose azocalix[4]arene, lysine azocalix[4]arene, serine azocalix[4]arene, carboxy azocalix[4]arene and sulfonated azocalix[4]arene have different upper edge substituents and can interact differently with different intracellular bacteria. The aqueous solutions of the azocalix[4]arene modified with the above substituents were mixed with the aqueous solutions of the commercially available probe 1,1',3,3,3',3'-hexamethylindolyl dicarbonyl cyanine in a ratio of 1:1 (the final concentrations of the probe and the calixarene were both 200 micromoles per liter for subsequent dilution), respectively, to form supramolecular host-guest complexes, and the eight sensing units thus formed were constructed together into a sensing array.
[0008] Due to the different substituents, each sensing unit approaches macrophages and bacteria to different degrees, providing comprehensive and complementary information. For signal transduction, azocalix[4]arene is complexed with the commercially available probe 1,1',3,3,3',3'-hexamethylindole dicarbonyl cyanine and its fluorescence is quenched. On the one hand, the formed host-guest sensing unit can restore fluorescence by competitive complexation with analytes on the surface of cells or bacteria. On the other hand, the hypoxic environment caused by bacterial infection promotes the reduction of the azo bond of calixarene and also leads to the release of the probe, resulting in different degrees of fluorescence onset. This supramolecular fluorescent octane sensing array can provide interactive response signals for the identification of different types of bacteria.
[0009] (2) Application of supramolecular fluorescence sensing array in diagnosis of intracellular bacterial infection types.
[0010] Eight bacteria (Salmonella typhimurium, Listeria monocytogenes, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Klebsiella pneumoniae, and Streptococcus mutans) were selected as target intracellular pathogens for proof of concept. In a black 96-well plate, the supramolecular array sensor units were incubated with cell samples infected with different bacteria, and five parallel experiments were performed for each sample. The fluorescence intensity of each well was tested using a fluorescence spectrometer equipped with a microplate reader accessory to obtain the fluorescence fingerprint of the supramolecular sensor array for intracellular bacterial samples ( Figure 3 ), each sensing unit exhibits a different fluorescence intensity level corresponding to the presence of a specific intracellular bacterium. The resulting fluorescence response data are then processed using linear discriminant analysis to obtain pattern recognition results ( Figure 4 ). The two-dimensional score plot showed that macrophages infected with eight bacteria and individual macrophages were well clustered into nine groups that were completely distinguishable from each other. Cross-validation using the “leave one out” method in linear discriminant analysis achieved a 100% discrimination accuracy, demonstrating that the constructed sensor array is very effective in identifying the presence and type of intracellular bacteria.
[0011] Furthermore, the ability of the supramolecular sensor array to identify intracellular bacteria was tested using mouse peritoneal fluid samples. Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa were injected into the peritoneum of different mice to cause infection, and macrophages in the peritoneal cavity were extracted by injecting phosphate buffer the next day. The sensor array of the present invention was applied to the extracted infected cell samples, and a linear discriminant analysis two-dimensional score map of the three bacteria-infected cells and healthy mouse cells was obtained. These clusters representing different analytes were clearly distinguished ( Figure 5 ). The data of the training set were substituted into the spectrum, and the blind sample was successfully verified to be an intracellular methicillin-resistant Staphylococcus aureus sample, demonstrating the potential of supramolecular fluorescence sensing arrays in practical applications.
[0012] (3) Principle of supramolecular fluorescence sensing array for intracellular bacterial identification We believe that the successful identification of intracellular bacteria mainly comes from three factors: differences in the interaction between calixarene and the surface of infected cells, differences in the ability of calixarene to be internalized by cells, and differences in the degree of anaerobic reduction of calixarene. We selected four representative calixarene (mannose azocalix[4]arene, lysine azocalix[4]arene, serine azocalix[4]arene, carboxy azocalix[4]arene) and six representative intracellular bacteria (Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Listeria monocytogenes, Salmonella typhimurium, Escherichia coli, Pseudomonas aeruginosa) to verify the above three conjectures.
[0013] First, an indicator displacement assay was performed by analyzing the fluorescence changes of macrophages infected with different bacteria added to the probe-calixarene complex. The increase in fluorescence intensity indicates the displacement of the probe from the calixarene cavity due to competitive binding. The observed fluorescence changes varied in magnitude, indicating different interactions between azocalix[4]arene and the analyte ( Figure 6 Next, the concentration of internalized azocalix[4]arene was quantified by examining the UV-visible spectra of the culture medium before and after co-culture with bacterially infected macrophages. Differences in the uptake of different azocalix[4]arene by each type of bacterially infected macrophage were observed ( Figure 7 ), verifying the interactive responsiveness provided by the sensing unit at this level. Finally, the reduction kinetics of azocalix[4]arene under anoxic conditions were studied. When sodium dithionite, an azoreductase mimetic, was added to the azocalix[4]arene solution, the UV absorption intensity decay curve of the azo bond was very consistent with the pseudo-first-order reaction model ( Figure 8 The rate constants of mannose azocalix[4]arene, lysine azocalix[4]arene, serine azocalix[4]arene, and carboxy azocalix[4]arene were 0.28, 2.05, 1.63, and 3.57 min, respectively.-1 , which indicates that the reduction kinetics of the selected calixarenes are different.
[0014] The advantages and beneficial effects of the supramolecular fluorescent sensor array for intracellular bacteria discrimination disclosed in the present invention compared with the prior art are: the supramolecular fluorescent sensor array of the present invention relies on the thermodynamic difference of the interaction and the kinetic difference of anaerobic reduction to cause changes in the release of fluorescent probes, thereby generating characteristic fingerprints of each intracellular bacterium. This discrimination method can conveniently, quickly and accurately distinguish eight tested intracellular bacteria without cell lysis, providing valuable guidance for the selection of antibiotics, thereby avoiding the misuse and overuse of antibiotics, and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] In order to more clearly introduce the technical solution of the present invention, the following is a brief introduction to the drawings required for use in the embodiments or prior art descriptions. Obviously, the drawings described below are only some embodiments of the present invention, and for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying additional creative work.
[0016] Figure 1 This is the H NMR spectrum of lysine azocalix[4]arene; Figure 2 This is the H NMR spectrum of serine azocalix[4]arene; Figure 3 The fluorescence response fingerprints of the supramolecular sensing array to eight intracellular bacteria and blank macrophages were obtained; Figure 4 The two-dimensional scoring map is obtained after the fluorescence data matrix after the supramolecular sensing array is applied to intracellular bacteria is processed by linear discriminant analysis; Figure 5 The two-dimensional scoring map obtained by applying the supramolecular sensor array to the fluorescence data matrix of intracellular bacteria in mouse peritoneal fluid samples processed by linear discriminant analysis; Figure 6 Fluorescence changes of supramolecular fluorescent host-guest pairs before and after addition to cells infected with bacteria; Figure 7 The uptake capacity of macrophages infected with Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Listeria monocytogenes, Salmonella typhimurium, Escherichia coli, and Pseudomonas aeruginosa for mannose-modified azocalix[4]arene, lysine-modified azocalix[4]arene, serine-modified azocalix[4]arene, and carboxyl-modified azocalix[4]arene; Figure 8The reduction kinetic fitting curves of mannose-modified azocalix[4]arene, lysine-modified azocalix[4]arene, serine-modified azocalix[4]arene, and carboxyl-modified azocalix[4]arene are shown. DETAILED DESCRIPTION
[0017] The following is a clear and complete description of the technical solutions in the embodiments of the present invention in conjunction with the accompanying drawings. The following embodiments are all implemented based on the technical solutions of the present invention, and detailed implementation processes have been given, but it must be stated that the protection scope of the present invention is not limited to the following embodiments. The sources of the raw materials used in the present invention are as follows: (1) Lactose-modified azocalix[4]arene (see: Li, J.-J.; Hu, Y.; Hu, B.; Wang, W.; Xu,H.; Hu, X.-Y.; Ding, F.; Li, H.-B.; Wang, K.-R.; Zhang, X.; Guo, D.-S., Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer. Nat. Commun. 2022,13, 6279.).
[0018] (2) Galactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas (see: Li, J.-J.; Hu, Y.; Hu, B.; Wang, W.; Xu, H.; Hu, aeruginosa infected diabetic ulcer. Nat. Commun. 2022,13, 6279.).
[0019] (3)Advanced chemicals[4]References: Li, S.; Li, J.-J.; Zhao, Y.-Y.; Chen , M.-M. ; Su, S.-S.; Yao, S.-Y.; Wang, Z.-H.; Hu, X.-Y.; Geng, W.-C.; Wang , W. ;Wang , KR ; Guo, D.-S.,Supramolecular integration of multifunctionalnanomaterial by mannose-decorated azocalixarene with ginsenoside Rb1 for synergistic therapy of rheumatoid arthritis. ACS Nano Rev. 2023, 17, 25468–25482.)
[0020] (4)References: Geng, Y.-Q.; Qiu, L.-N.; Cheng , Y.-Q. ; Li, J.-J.; Ma, Y.-L.; Zhao, C.-C.; Cai, Y.; Zhang, X.-B.; Chen , J. ; Pan,Y.; Wang, K.-R.; Yao, X.-H.; Guo, D.-S.; Wu, J.-L.,Alleviating recombinant plasminogen activator-induced hemorrhagic transformation in ischemic stroke via targeted delivery of a ferroptosis inhibitor. Adv. Sci. 2024.2309517.).
[0021] ((5)surface-based[4]synthesis(references):Geng, W.-C.; Jia, S.; Zheng , Z. ; Li , Z. ;Ding , D. ; Guo, D.-S., A noncovalent fluorescence turn-on strategy for hypoxia imaging. Angew. Chem. Int. Ed. Rev. 2019, 58, 2377–2381. (6) Sulfonated azocalix[4]arenes (see: Zhang, T.-X.; Hou, Theranostics 2022, 12, 396-409.) Example 1: Synthesis of Lysine Azocalix[4]arene
[0022] Carboxy azocalix[4]arene (200 mg, 0.20 mmol), 1-ethyl-(3-dimethylaminopropyl)carbodiimide (310 mg, 2.0 mmol) and N-hydroxysuccinimide (230 mg, 2.0 mmol) were dissolved in N,N-dimethylformamide (20 mL). The solution was stirred at room temperature for 2 hours and precipitated with excess water. The precipitate was dissolved in N,N-dimethylformamide (40 mL) and added to a round-bottom flask premixed with N(e)-Boc-l-lysine (394 mg, 1.6 mmol), sodium carbonate (21 mg, 2.0 mmol), N,N-dimethylformamide (10 mL) and water (10 mL). The mixture was stirred at room temperature for 24 hours and precipitated with 300 mL of dilute hydrochloric acid. The precipitate was placed in 50 ml of trifluoroacetic acid and stirred for 24 hours. The liquid was evaporated to dryness and the obtained solid was recrystallized from methanol and water to obtain 272 mg of brick-red lysine azocalix[4]arene with a yield of 90%.
[0023] As attached Figure 1 As shown, the compound lysine azocalix[4]arene 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.75 (d, J = 7.1 Hz, 4H; NH), 8.02 (d, J = 8.2 Hz, 8H; Ar-H), 7.95 (s, 8H;NH 2 ), 7.84 (s, 8H; Ar-H), 7.83 (d, J = 8.1 Hz, 8H; Ar-H), 4.36 (m, 4H; CH), 2.77 (m, 8H; CH2 ), 1.81 (m, 8H; CH 2 ), 1.58 (m, 8H; CH 2 ), 1.43 (m, 8H; CH 2 )ppm. Example 2: Synthesis of Serine Azocalix[4]arene
[0024] Carboxy azocalix[4]arene (200 mg, 0.20 mmol), 1-ethyl-(3-dimethylaminopropyl)carbodiimide (310 mg, 2.0 mmol) and N-hydroxysuccinimide (230 mg, 2.0 mmol) were dissolved in N,N-dimethylformamide (20 ml), stirred at room temperature for 2 hours, and precipitated with excess water. The precipitate was dissolved in N,N-dimethylformamide (40 ml) and added to a round-bottom flask pre-mixed with l-serine (168 mg, 1.6 mmol), sodium carbonate (212 mg, 2.0 mmol), N,N-dimethylformamide (10 ml) and water (10 ml). Stirred at room temperature for 24 hours, precipitated with 300 ml of dilute hydrochloric acid. The precipitate was recrystallized from methanol and water to obtain 235 mg of brick-red serine azocalix[4]arene with a yield of 88%.
[0025] As attached Figure 2 As shown, the compound serine azocalix[4]arene 1 H NMR (400 MHz, DMSO- d 6 ) δ 8.54 (d, J = 7.6 Hz, 4H; NH), 8.01 (d, J = 8.6 Hz, 8H; Ar-H), 7.86 (s, 8H; Ar-H), 7.84 (d, J = 8.6 Hz, 8H; Ar-H), 4.47 (m, 4H; CH), 4.42 (m, 4H; CH) 2 ),2.80 (d, J = 6.5 Hz, 8H; CH 2 ), 2.70 (m, 4H; CH 2 ) ppm. Example 3: Identification of intracellular bacteria Mouse mononuclear macrophage leukemia cells were cultured at 5 × 10 5 Cells were seeded at a density of 1:1 in 6-well plates and incubated in 5% CO 2 / 95% air overnight. Then the bacteria (OD 600 = 2.0, 100 μl) was used to infect cells at 37°C for phagocytosis. After 1 hour of infection, the culture medium was removed. The bacterially infected cells were incubated with the probe@azocalix[4]arene complex (20@20 μmol / l) for 1 hour. Subsequently, the cells were washed with phosphate buffer and the fluorescence intensity of the cell suspension was measured at an excitation wavelength of 630 nm. The fluorescence intensity at 650 nm was obtained for the response signal of the sensing analysis of the array. Each experiment was repeated 5 times. Finally, the raw data matrix was processed using linear discriminant analysis in the Past 3 program to obtain a two-dimensional score map.
[0026] Example 4: Identification of intracellular bacteria in mouse peritoneal fluid samples The mice were randomly divided into 4 groups ( n =5) were injected intraperitoneally with phosphate buffer, methicillin-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa solutions (OD 600 =1.0, 5 μl). In addition, three mice were injected with methicillin-resistant Staphylococcus aureus solution (OD 600 = 1.0, 5 μl) for blind sample testing in the training set. The next day, the mice were sacrificed and injected intraperitoneally with 2 ml of phosphate buffered saline. The abdomen of the mice was gently pressed and the peritoneal extract was extracted. The supramolecular sensor array was applied to the extracted mouse bacterial infected cell samples using the above method.
[0027] Example 5: Interaction of azocalixarene with macrophages The fluorescence emission of the probe 1,1',3,3,3',3'-hexamethylindole dicarbonyl cyanine was tested in the range of 640 to 800 nm using an excitation wavelength of 630 nm. First, 2.5 ml of a solution of 1,1',3,3,3',3'-hexamethylindole dicarbonyl cyanine and azocalixarene complex (1.0 μmol / L) was added to a fluorescent quartz cell and its fluorescence intensity was recorded. Bacterial-infected macrophages were cultured in six-well plates according to the protocol in Example 3 and then resuspended in culture medium for counting. A total of 2´10 3 The infected cells were transferred into a fluorescent quartz cell containing a supramolecular fluorescent complex solution to interact with the host-guest pair, and the fluorescence of the dye was recorded after equilibrium.
[0028] Example 6: Cellular Uptake Activity of Azocalixarene Mouse mononuclear macrophage leukemia cells were cultured at 5´ 10 5 Cells were seeded at a density of 100 cells / well in a 6-well plate and allowed to adhere overnight. They were then incubated at 37°C with bacteria (Staphylococcus aureus, MRSA, Listeria monocytogenes, Salmonella typhimurium, Escherichia coli, Pseudomonas aeruginosa, OD600 = 2.0, 100 μl) to infect cells for phagocytosis. After 1 hour of infection, the medium was removed. The bacterially infected cells were incubated with mannose-modified azocalix[4]arene, lysine-modified azocalix[4]arene, serine-modified azocalix[4]arene, and carboxyl-modified azocalix[4]arene (80 μmol / l) at 37°C for 1 hour. The concentration of azocalix[4]arene remaining in the supernatant was quantified by UV-visible spectroscopy to obtain the concentration of azocalix[4]arene taken up by the infected cells. A standard curve of absorbance was prepared using each azocalix[4]arene in the concentration range of 0, 10, 20, 40, 80, and 100 μmol / l.
[0029] Example 7: Reduction Kinetics of Azocalixarene The reduction kinetics of mannose-modified azocalix[4]arene, lysine-modified azocalix[4]arene, serine-modified azocalix[4]arene, and carboxyl-modified azocalix[4]arene were monitored by UV-visible spectroscopy. Excess sodium dithionite (2.3 mmol / L) was injected into 2.5 mL of azocalixarene solution (10.0 μmol / L) to monitor the absorbance of azocalixarene at 420 nm over time at 37°C.
[0030] The above description is only a preferred embodiment of the present invention. It should be pointed out that a person skilled in the art can make several modifications and improvements without departing from the inventive concept, which all belong to the protection scope of the present invention.
Claims
1. A supramolecular fluorescence sensing array, Features It is composed of azocalixarene loaded with a fluorescent indicator, and eight sensor units formed thereby are jointly constructed into a sensor array, wherein the molar concentration ratio of azocalixarene to the fluorescent indicator is 1:1; the fluorescent indicator is 1,1',3,3,3',3'-hexamethylindole dicarbonyl cyanine; The structure of the azocalixarene is as follows: 。 2. The method for preparing the supramolecular fluorescence sensor array according to claim 1, Features Proceed as follows: (1) mixing aqueous solutions of lactose azocalix[4]arene, galactose azocalix[4]arene, mannose azocalix[4]arene, glucose azocalix[4]arene, lysine azocalix[4]arene, serine azocalix[4]arene, carboxy azocalix[4]arene and sulfonated azocalix[4]arene with an aqueous solution of fluorescent probe 1,1',3,3,3',3'-hexamethylindolyl dicarbonyl cyanine at a molar concentration ratio of 1:1; (2) Each azocalixarene cavity-bound fluorescent probe molecule forms a supramolecular complex. The final concentration of the eight supramolecular complexes is 200 μmol / L for subsequent dilution. (3) These eight supramolecular complexes are used as sensing units to construct a sensing array, which is then co-incubated with analytes to test the fluorescence response intensity generated by the sensing array; The preparation method of the lysine azocalix[4]arene is as follows: 0.20 mmol of carboxy azocalix[4]arene, 2.0 mmol of 1-ethyl-(3-dimethylaminopropyl)carbodiimide and 2.0 mmol of N-hydroxysuccinimide are dissolved in 20 ml of N,N-dimethylformamide, the solution is stirred at room temperature for 2 hours, and precipitated with excess water; the precipitate is dissolved in 40 ml of N,N-dimethylformamide, added to a round-bottom flask pre-mixed with 1.6 mmol of N(e)-Boc-l-lysine, 2.0 mmol of sodium carbonate, 10 ml of N,N-dimethylformamide and 10 ml of water, the mixture is stirred at room temperature for 24 hours, and precipitated with 300 ml of dilute hydrochloric acid; the precipitate is placed in 50 ml of trifluoroacetic acid and stirred for 24 hours, the liquid is evaporated to dryness, and the obtained solid is recrystallized with methanol and water to obtain 272 mg of brick red lysine azocalix[4]arene; The preparation method of the serine azocalix[4]arene is as follows: 0.20 mmol of carboxy azocalix[4]arene, 2.0 mmol of 1-ethyl-(3-dimethylaminopropyl)carbodiimide and 2.0 mmol of N-hydroxysuccinimide are dissolved in 20 ml of N,N-dimethylformamide, stirred at room temperature for 2 hours, and precipitated with excess water; the precipitate is dissolved in 40 ml of N,N-dimethylformamide, added to a round-bottom flask pre-mixed with 1.6 mmol of l-serine, 2.0 mmol of sodium carbonate, 10 ml of N,N-dimethylformamide and 10 ml of water, stirred the mixture at room temperature for 24 hours, and precipitated with 300 ml of dilute hydrochloric acid. The precipitate is recrystallized with methanol and water to obtain 235 mg of brick-red serine azocalix[4]arene.
3. Use of the supramolecular fluorescent sensor array according to claim 1 in diagnosing the type of intracellular bacterial infection.
Citation Information
Cited By
Fluorescent array sensing system based on bionic taste sense, construction method of fluorescent array sensing system and application of fluorescent array sensing system in food safety intelligent detection
CN121185994A
A fluorescent array sensing system based on biomimetic taste and construction method thereof and application in food safety intelligent detection
CN121185994B
Multifunctional supramolecular nano platform and application thereof
CN121221800A
